FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Factor patents



      
           
This page is updated frequently with new Factor-related patents. Subscribe to the Factor RSS feed to automatically get the update: related Factor RSS feeds.

Subscribe to updates on this page: Factor RSS RSS

Date/App# patent app List of recent Factor-related patents
04/17/14
20140108299
 Transformation weighted indexes offering concentrated multi-risk factor exposure patent thumbnailnew patent Transformation weighted indexes offering concentrated multi-risk factor exposure
Computer-based systems, software, and computer-implemented methods for creating an index of securities based upon various data transformations of risk factor metrics regarding entities or securities associated with the entities and weighting each index member in proportion to its combined transformed weighting value.. .
04/17/14
20140108021
 Method and apparatus for encoding audio data patent thumbnailnew patent Method and apparatus for encoding audio data
A method for processing audio data includes determining a first common scalefactor value for representing quantized audio data in a frame. A second common scalefactor value is determined for representing the quantized audio data in the frame.
04/17/14
20140107206
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107205
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107200
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty adds, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107199
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids comprising omega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107198
 Omega-3 pentaenoic acid compositions and methods of use patent thumbnailnew patent Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/17/14
20140107025
 Ocular drug delivery system patent thumbnailnew patent Ocular drug delivery system
An ocular drug delivery system including a composition in which a formulation having an active agent such as rhgh and or an rhgh mimic, e.g., that increases insulin growth factor (igf) or that alters insulin growth factor binding protein (igfbp) in a subject is dispersed in a pharmaceutical carrier. The composition is configured for placement in, around or on an eye of the subject, and the composition provides controlled release of an amount of the active agent to the eye effective to promote ocular surface and corneal neural regeneration and wound healing..
04/17/14
20140107022
 Chimeric fibroblast growth factor 19 proteins and methods of use patent thumbnailnew patent Chimeric fibroblast growth factor 19 proteins and methods of use
The present invention relates to a chimeric protein that includes an n-terminus coupled to a c-terminus, where the n-terminus includes a portion of a paracrine fibroblast growth factor (“fgf”) and the c-terminus includes a c-terminal portion of an fgf19 molecule. The portion of the paracrine fgf is modified to decrease binding affinity for heparin and/or heparan sulfate compared to the portion without the modification.
04/17/14
20140106819
 Compact form factor integrated circuit card and methods patent thumbnailnew patent Compact form factor integrated circuit card and methods
A compact form factor integrated circuit card. In one embodiment, a subscriber identity module (sim) card is disclosed.
04/17/14
20140106405
new patent Mammalian cell culture processes for protein production
The present invention describes methods and processes for the production of proteins by animal cell or mammalian cell culture. In one aspect, the methods comprise the growth of cells in a growth factor/protein/peptide free medium.
04/17/14
20140106383
new patent Electrochemical determination of factor xa inhibitors
Methods and devices for determining factor xa inhibitors, in particular heparins and fractionated or low-molecular-weight heparins, as well as direct factor xa inhibitors in blood samples. The methods include contacting a blood sample with a detection reagent that contains at least one thrombin substrate having a peptide residue that can be cleaved by thrombin and is amidically bound via the carboxyl end to an electrogenic substance, and with a known amount of factor x reagent and an activator reagent which induces the conversion of factor x into factor xa.
04/17/14
20140105990
new patent Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
The present invention is relevant to human medicine, and, in particular, to the use of epidermal growth factor (egf) in a pharmaceutical composition, said composition is administered through infiltration at the periphery of nerve trunks and/or ganglia, for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as ischemic neuritis. It is also relevant to an egf containing composition, where this molecule can be formulated together with anesthetic or analgesic drugs, or encapsulated in microspheres, and their use for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as in ischemic neuritis..
04/17/14
20140105933
new patent Methods for assessing cancer recurrence
Certain embodiments are directed to methods of identifying a subject having a higher risk of prostate cancer recurrence. The methods can include the step of measuring levels of one or more of flip, transcription factor sp1, and transcription factor sp3 in a prostate sample from the subject, wherein elevated levels of flip, transcription factor sp1, and transcription factor sp3 identify a subject as high risk for prostate cancer recurrence..
04/17/14
20140105860
new patent Engineered antibody-tnfsf member ligand fusion molecules
The field of the present invention relates to genetically engineered fusion molecules, methods of making said fusion molecules, and uses thereof in anti-tumor immunotherapies. More specifically, the present invention relates to engineered fusion molecules comprising an antibody (ab) which can target tumor cells (e.g., rituxin®), fused to one or more biologic moieties capable of inducing apoptosis in tumor cells, e.g., tumor necrosis factor super family (tnfsf) member ligands such as tnf-α, cd40l, cd95l (also “fasl/apo-1l”) and trail/apo-2l.
04/17/14
20140105831
new patent Liquid detergent composition with abrasive particles
A composition comprising abrasive particles derived from inorganic-based foam, wherein said abrasive particles are non-spherical having a form factor from 0.1 to 0.6 and a solidity from 0.3 to 0.9, and wherein said abrasive particles comprise one or more inorganic materials and have a mohs hardness of from 1 to 4.. .
04/17/14
20140105821
new patent Antibody that stops or slows tumour growth (variants)
A monoclonal antibody is described herein specifically binding to domains ii and iiic of fgfr1 or to a complex of fibroblast growth factor receptor type 1 and heparan sulphate. A method is proposed for suppressing tumour growth, based on blocking the human fibroblast growth factor/human fibroblast growth factor receptor type 1 (domains ii and iiic) pathway and involves administering the antibody.
04/17/14
20140105495
new patent Method, apparatus and system for converging images encoded using different standards
A method for transforming an image expressed in terms of a first image encoding to a second image encoding, includes converting a set of original scene exposure-factor values into corresponding first and second image encoding values. A transform is then derived between the first image encoding values and the second image encoding values.
04/17/14
20140104807
new patent Esd protection in a very small form factor consumer electronic product
A very small form factor consumer electronic product includes at least a single piece housing having an integral front and side walls that cooperate to form a cavity in cooperation with a front opening where an edge of the side walls define a rear opening and at least some of the edges have flanges. The consumer electronic product also includes an user input assembly having a size and shape in accordance with the front opening and a clip assembly having a size and shape in accordance with the rear opening and having an external user actionable clip, a plurality of internal hooking features, and a plurality of internal latching features.
04/10/14
20140101453
Real identity authentication
A real identity biometric authentication device includes a usb thumb drive form factor, with a biometric sensor and designated device processor and stored instructions in firmware which perform authentication in a secure manner, independent of processing and storage resources on a host platform. The device and authentication process require biometric data and are secured against effects of malware or other security risks presented by applications running on the host platform.
04/10/14
20140101426
Portable, secure enterprise platforms
A portable, secure enterprise computing platform is provided by a device having a storage or memory, including a firmware module, a processor and an interface for interfacing with a host platform. The interface may be a usb interface and the device may have the form factor of a usb thumb drive.
04/10/14
20140100858
System and method for identification of risk indicators based on delays in answering survey questions
In a telehealth system, a telehealth terminal presents a survey question to a patient. The patient enters a response to the survey question with the telehealth terminal.
04/10/14
20140100281
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/10/14
20140100161
System and method for multiphasic release of growth factors
A system for multiphasic delivery of at least one growth factor at a treatment site comprises a delivery vehicle for releasing at least one growth factor in an initial release profile and a carrier for releasing at least one growth factor in a sustained release profile. The initial release profile releases at least one growth factor over a period of hours to days, wherein the growth factor is released in a large amount initially, with the remainder being released in progressively lower amounts.
04/10/14
20140100160
Novel use of c-terminal domain of igfbp-5 comprising heparin-binding domain as an angiogenesis inhibitor
The present invention relates to a pharmaceutical composition for inhibiting angiogenesis comprising an isolated peptide comprising the heparin-binding domain of insulin-like growth factor-binding protein-5 (igfbp-5), a method for inhibiting angiogenesis using the peptide, a pharmaceutical composition for the prevention or treatment of cancer comprising the peptide, a method for treating cancer using the peptide, a novel angiogenesis-inhibiting peptide derived from heparin-binding domain of igfbp-5, a polynucleotide encoding the peptide, an expression vector comprising the polynucleotide and a transformant comprising the vector.. .
04/10/14
20140099729
Methods and apparatus for artificial olfaction
In exemplary implementations of this invention, an electronic olfactor determines whether a scent being tested matches the scent of a positive control. The electronic olfactor can perform this scent matching even in a changing olfactory environment, and even if the positive control scent is a combination of hundreds or thousands of different odorants.
04/10/14
20140099710
Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
The present invention is directed to a method of deriving pluripotent embryonic stem cells from mouse blastocysts or from primordial germ cells from a post-implantation mouse embryo, or of maintaining or growing pluripotent embryonic stem cells from a mouse, or of expanding human hematopoietic stem cells or human hematopoietic precursor cells. The methods include the step of cultivating the stem cells or precursor cells for at least one passage in a culture medium preconditioned by the rabbit fibroblast cell line rab9 (atcc catalogue crl1414) and containing less than 0.1 ng/ml leukemia inhibitory factor (lif)..
04/10/14
20140099359
Synthetic platelets
A synthetic platelet includes a biocompatible flexible nanoparticle that includes an outer surface and a plurality of peptides conjugated to the surface, the peptides including a plurality of von willebrand factor-binding peptides (vbps), collagen-binding peptides (cbps) and an active platelet gpiib-iiia-binding peptides (gbps).. .
04/10/14
20140098288
Small form factor modules using wafer level optics with bottom cavity and flip-chip assembly
A disclosed method of manufacturing a camera module includes providing a stack of optical elements, providing an integrated circuit image capture device (icd) having a top surface with an array of sensors, rigidly attaching the stack of optical elements to top surface of the image capture device, providing a substrate having an opening therethrough and a recess around said opening, and attaching the image capture device to the substrate such that edges of the image capture device are disposed in the recess and the stack of optical elements extends through the opening. The method further includes providing a second substrate (e.g., host pcb) and mounting the substrate on the second substrate to attach the camera module to the host device.
04/10/14
20140098238
Infrared camera system architectures
Various techniques are disclosed for providing an infrared imaging module that exhibits a small form factor and may be used with one or more portable devices. Such an infrared imaging module may be implemented with a housing that includes electrical connections that may be used to electrically connect various components of the infrared imaging module.
04/03/14
20140096283
Plants having enhanced yield-related traits and a method for making the same
The present invention relates generally to the field of molecular biology and concerns a method for enhancing various yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a tcp1 or a tcp2 transcription factor, an epsin-like polypeptide, a trna delta(2)-isopentenylpyrophosphate transferase (ippt) polypeptide, or a short-root (shr) polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding a tcp1 or tcp2 polypeptide, an epsin-like polypeptide, a trna delta(2)-isopentenylpyrophosphate transferase (ippt) polypeptide, or a short-root (shr) polypeptide, which plants have enhanced yield-related traits relative to corresponding wild type plants or other control plants.
04/03/14
20140095570
Apparatus and method for calculating internal state for artificial emotion
An apparatus and method for calculating an internal state for artificial emotions are disclosed, of which the method comprises multiplying an input value obtained from a sensor with a first personality set in accordance with at least one low rank element contained in at least one high rank element of a neo pi-r (revised neo personality inventory); calculating a personality factor value in a five-factor model of the personality by adding the results of the multiplication; and calculating the internal state by multiplying the personality factor value with a second personality.. .
04/03/14
20140095186
Identifying group and individual-level risk factors via risk-driven patient stratification
Systems and methods for individual risk factor identification include identifying common risk factors for one or more risk targets from population data. Individuals are stratified into clusters based upon the common risk factors.
04/03/14
20140095184
Identifying group and individual-level risk factors via risk-driven patient stratification
Systems and methods for individual risk factor identification include identifying common risk factors for one or more risk targets from population data. Individuals are stratified into clusters based upon the common risk factors.
04/03/14
20140094520
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/03/14
20140094502
Rnai inhibition of ctgf for treatment of ocular disorders
Rna interference is provided for inhibition of connective tissue growth factor mrna expression in ocular disorders involving ctgf expression. Ocular disorders involving aberrant ctgf expression include glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing.
04/03/14
20140094413
Hepatocyte growth factor (hgf) mimics as therapeutic agents
Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, alzheimer's disease, parkinson's disease, amyotrphic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, cancer, and defective wound healing..
04/03/14
20140094406
Chimeric fibroblast growth factor 21 proteins and methods of use
The present invention relates to a chimeric protein that includes an n-terminus coupled to a c-terminus, where the n-terminus includes a portion of a paracrine fibroblast growth factor (“fgf”) and the c-terminus includes a c-terminal portion of an fgf21 molecule. The portion of the paracrine fgf is modified to decrease binding affinity for heparin and/or heparan sulfate compared to the portion without the modification.
04/03/14
20140094114
Biosample cartridge with radial slots for storing biosample carriers and using in automated data storage systems
Embodiments of the disclosure relate to a biosample cartridge that includes radial slots for storing biosample carriers. The biosample cartridge has the same form factor as data tape cartridges used in automated tape libraries to allow the biosample cartridge to be handled by the same robotic mechanisms that handle the data tape cartridges.
04/03/14
20140094054
Credit card shaped charging and data cable
A data and charging cable includes a body portion having a form factor substantially like that of a credit card, including a slot extending from a first end of the body portion toward a second end of the body portion. The cable includes an elastomeric tongue having a proximal end pivotably attached to the first end of the body portion and a distal end removably attached to the body portion by a detent mechanism.
04/03/14
20140093890
Quantitative assays for ras p21 in body fluids
The present invention is directed to the detection and quantification of total ras p21 in body fluids, particularly serial changes of total ras p21 levels in a subject's body fluids. Further, the invention is directed to detecting and quantitating total ras p21 in conjunction with one or more other proteins, such as, oncoproteins, angiogenic factors, tumor markers, inhibitors, growth factor receptors, metastasis proteins, and tumor suppressors.
04/03/14
20140093568
Combination therapies
The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer..
04/03/14
20140093520
Vegf-d/vegfr2/3-mediated regulation of dendrites
The present invention relates to methods for modulating, i.e. Increasing or decreasing, the length and/or the complexity of the dendrites of a neuronal cell by influencing the amount of vascular endothelial growth factor d (vegfd)-related signaling.
04/03/14
20140093491
Recombinant or transgenic factor vii composition, each factor vii molecule having two n-glycosylation sites with defined glycan units
The invention is related to a composition of recombinant or transgenic factor vii, each molecule of factor vii of the composition exhibiting two n-glycosylation sites, wherein, among all the molecules of fvii of the composition, the rate of galα1,3g al glycan moieties is comprised between 0 and 4%. The invention is also related to a process for preparing such a composition of fvii..
04/03/14
20140093133
Systems and methods for monitoring vehicle occupants
Various techniques are disclosed for systems and methods using small form factor infrared imaging modules to monitor occupants in an interior compartment of a vehicle. For example, a vehicle-mounted system may include one or more infrared imaging modules, a processor, a memory, alarm sirens, and a communication module.
04/03/14
20140091428
Land side and die side cavities to reduce package z-height
A package structure including a capacitor mounted within a cavity in the package substrate is disclosed. The package structure may additionally include a die mounted to a die side surface of the package substrate, and the opposing land side surface of the package substrate may be mounted to a printed circuit board (pcb).
03/27/14
20140088100
Inhibitors of the fibroblast growth factor receptor
Described herein are inhibitors of fgfr, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.. .
03/27/14
20140088072
Extended risk assessment panel for individualized treatment of cardiovascular disease, and methods related thereto
Disclosed is a personalized diagnostic and treatment solution for cardiovascular disease. The invention comprises an extended cvd risk assessment panel, combining tests for traditional and new important risk markers, and methods for devising a personalized treatment plan for a patient via the use of a cvd diagnosis and treatment protocol algorithm.
03/27/14
20140088004
Hepatocyte growth factor mimics as therapeutic agents
Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing..
03/27/14
20140087400
Diagnosis and prognosis of triple negative breast and ovarian cancer
In one aspect, the present disclosure provides a method of predicting disease progression comprising: (a) obtaining a sample of breast tissue that is estrogen receptor negative, progesterone receptor negative and does not over-express human epidermal growth factor 2 receptor protein; and (b) determining the expression of glia maturation factor beta, wherein expression of glia maturation factor beta is indicative of lymph node metastatis. In another aspect, the present disclosure provides a method of predicting disease progression comprising: (a) obtaining a sample of breast tissue that is estrogen receptor negative, progesterone receptor negative and does not over-express human epidermal growth factor 2 receptor protein; and (b) determining the expression of glia maturation factor beta, wherein expression of glia maturation factor beta is indicative of an untreated or treated prognosis that is reduced compared to an absence of the expression..
03/27/14
20140087237
Lead-acid battery design having versatile form factor
An electrochemical storage device comprises a plurality of layer electrodes each including a first charged sector and a second charged sector. The plurality of layer electrodes are assembled with respect to each other such that the first charged sector of a first plate of the plurality of layer electrodes is laid below the second charged sector of a second plate of the plurality of layer electrodes located immediately above the first plate.
03/27/14
20140087002
Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat lymphedema and to improve reconstructive surgery
Materials and methods are provided to improve survival of lymph nodes and integration of lymph nodes into a lymphatic network, following lymph node transplantation. The treatment or prevention of lymphedema is also addressed.
03/27/14
20140086904
Humanized anti-tnf-alpha antibody and antigen-binding fragment (fab) thereof and use of the same
The present invention discloses a humanized anti-human tumor necrosis factor-α antibody and antigen-binding fragment (fab) thereof. The present invention also discloses a composition comprising the said antibody or antigen-binding fragment (fab) thereof, and the use of the said antibody or antigen-binding fragment (fab) thereof in treating the diseases associated with tumor necrosis factor-α..
03/27/14
20140086887
Adult stem cell line introduced with hepatocyte growth factor gene and neurogenic transcription factor gene with basic helix-loop-helix motif and uses thereof
The present invention relates to an adult stem cell line introduced with an hgf gene and a neurogenic transcription factor gene of a bhlh family, a preparation method of the adult stem cell line, a composition for the prevention or treatment of neurological diseases comprising the adult stem cell line, and a method for treating neurological diseases comprising the step of administering the composition to a subject having neurological diseases or suspected of having neurological diseases. The adult stem cells according to the present invention, which are introduced with an hgf gene and a neurogenic transcription factor gene of a bhlh family, can be used to overcome chronic impairment caused by cell death following stroke.
03/27/14
20140086830
Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
The present invention provides compositions and methods of use of anti-igf-1r antibodies or antibody fragments. Preferably the antibodies bind to igf-1r but not ir; are not agonists for igf-1r; do not block binding of igf-1 or igf-2 to isolated igf-1r, but effectively neutralize activation of igf-1r by igf-1 in intact cells; and block binding of an r1 antibody to igf-1r.
03/27/14
20140086829
Recombinant antibodies to the vascular endothelial growth factor (vegf) which are obtained by means of mutagenesis of variable regions
The present invention reveals human recombinant antibodies that recognize the human vascular endothelium growth factor a (vegf-a), block its interaction with the vegfr2 receptor, and interfere with its proliferative effect in vitro and pro-angiogenic effect in vivo. The antibodies identify an epitope on human vegf-a different from any other previously reported, and were obtained by combining one immunoglobulin light chain variable region with other three heavy chain ones.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Factor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Factor with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2957

3525

5 - 0 - 74